Wenjing Chen

Wenjing Chen is an experienced professional in the fields of medical sales, research, and management. Currently serving as the International Sales Manager at scil animal care company GmbH since December 2022, Wenjing previously founded and led DEXIN Med GmbH from March 2018 to December 2022, facilitating medical travel, training, and scientific communication between China and Germany. Additional experience includes roles as a researcher at the Heidelberg Ion-Beam Therapy Center and a biotechnologist at University Hospital Heidelberg, contributing to heavy ion beam therapy. Earlier career highlights include early stage research at Siemens Healthcare and an internship at Philips focused on diffuse optical tomography. Wenjing holds an MBA from the German Graduate School of Management and Law, a Doctorate in Medical Physics from Heidelberg University, and multiple degrees in Biomedical Engineering from Chalmers University of Technology and Southeast University.